DELTA 9 CANNABIS INC. (TSXV: NINE) has entered into a non-binding letter of intent to become a preferred supplier of medical cannabis to Pharmasave.
Pharmasave is a member owned and governed cooperative of more than 650 independent community pharmacies across Canada. Pharmasave believes that pharmacists, as medication management experts, play an important role in helping to improve patient care. For more than a year, Pharmasave has been providing education and resources on medical cannabis to help Pharmasave pharmacists understand more about the current regulations and learn more about the possible uses, benefits and risks of medical cannabis. Pharmacists can provide advice on potential drug-to-drug interactions and the therapeutic value of treatment options to patients and allied health professionals to help them make educated and informed decisions about products and monitoring.
Following execution of the Letter of Intent, the two companies are jointly working to conclude definitive agreements for supply and distribution of Delta 9's medical cannabis through Pharmasave pharmacists, pending changes to Canadian legislation that would allow such distribution.
Delta 9 CEO John Arbuthnot says the agreement is part of Delta 9's ongoing commitment to supplying patients with the medical products they need in a timely and reliable manner.
"There has been a lot of discussion about the upcoming legalization of recreational cannabis, but we at Delta 9 remain committed to providing our medical cannabis patients with the products they require," Arbuthnot said. "Pharmasave and its member stores provide the expertise and professionalism this industry needs to ensure patients are receiving the correct products, and good advice on how to use these products for their particular condition or symptoms."
"We believe this agreement with Pharmasave is a critical part of professionalizing the medical cannabis industry, and we are dedicated to providing the best products and service possible to our patients."
The parties are currently working on agreement terms to ensure compliance with the Access to Cannabis for Medical Purposes Regulations (Canada) and all other applicable laws and regulations.
About Delta 9 Cannabis Inc.
Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical marijuana pursuant to the ACMPR and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9's shares trade on the TSX Venture Exchange under the symbol "NINE".
Read Original Release
Read More
Delta 9 Cannabis Inc. Signs Letter of Intent with Pharmasave
